Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FPAQY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,344
Award facts
- Contract value 100% obligated
- $7,344.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $7,344.32 for Dupixent 300 mg/2 ml syringes. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499.999 billion and valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for DLA contracts. The company specializes in distributing a broad portfolio of pharmaceutical products to military and federal healthcare facilities nationwide, including branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for Dupixent, a specialty medication, reflects the company's ongoing role in supporting the Department of Defense's healthcare supply requirements across its global network of military health facilities.
Quick answers
Who was awarded contract SPE2DB25FPAQY?
SPE2DB25FPAQY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FPAQY worth?
The government has obligated $7,344 on SPE2DB25FPAQY.
Is contract SPE2DB25FPAQY an order under another contract?
Yes. SPE2DB25FPAQY is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQY competed?
The extent of competition for SPE2DB25FPAQY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award